The Drum · Weekly AI news, freeSubscribe →
Share
Anthropic is pushing the boundaries of AI by enhancing its Claude model specifically for life sciences, aiming to boost biomedical research and drug discovery at an unprecedented pace.
In a world where medical breakthroughs can mean the difference between life and death, accelerating scientific progress is more than just a technological challenge-it's a moral imperative. Anthropic, a leading AI research company, understands this deeply. They are committed to building tools that not only assist researchers but also have the potential to make autonomous discoveries in the future.
Until recently, scientists and industry professionals used Claude, Anthropic’s advanced AI model, primarily for individual tasks such as writing code for statistical analysis or summarizing research papers. However, the company has set its sights higher. Their goal is to transform Claude into a comprehensive tool that supports every stage of scientific discovery, from early research through translation and commercialization.
At the heart of this transformation is the introduction of Claude Sonnet 4.5, Anthropic’s most advanced model yet. This new iteration shows significant improvements over its predecessors in various life sciences tasks. For instance, on Protocol QA-a benchmark that tests the model's understanding and facility with laboratory protocols-Sonnet 4.5 scores 0.83, surpassing both the human baseline of 0.79 and Sonnet 4’s performance of 0.74. Similar improvements are evident in bioinformatics tasks, as measured by BixBench.
To make Claude even more useful for scientific work, Anthropic is rolling out several new connectors to key platforms used in life sciences research. These connectors allow Claude to interact directly with these tools, streamlining the research process and enhancing collaboration:
These new connectors build upon Anthropic’s existing set of general-purpose tools, such as Google Workspace and Microsoft SharePoint, further enhancing Claude's versatility.
In addition to these technical advancements, Claude is being equipped with Agent Skills, which are pre-built capabilities designed for specific tasks. This feature will make it easier for researchers to leverage Claude’s abilities without needing extensive programming knowledge. Anthropic is also providing a prompt library and dedicated support tailored specifically for life sciences professionals, including researchers, clinical coordinators, and regulatory affairs managers.
The improvements to Claude are not just about making the AI smarter; they are about empowering scientists to do their best work. By reducing the time spent on routine tasks and providing access to a wealth of scientific resources, Claude can help researchers focus more on innovation and discovery. This could lead to faster development of new treatments, better understanding of diseases, and ultimately, improved patient outcomes.
As AI continues to evolve, its potential to revolutionize life sciences research is becoming increasingly clear. Anthropic’s enhancements to Claude represent a significant step forward in this journey, bringing us closer to a future where AI is not just an assistant but a true partner in scientific discovery.
Tags
Original Sources
About the author
Amara's entry point into AI was an epidemiology role at a London research hospital, where she spent five years studying how digital health tools reached — or conspicuously failed to reach — underserved communities. Watching early algorithmic systems in healthcare quietly entrench existing inequalities, she redirected her career toward the systemic consequences of AI at scale. She covers AI through an unflinching lens: who benefits, who bears the cost, and what evidence actually says versus what the press release claims. Her writing is calm and precise, but she doesn't mistake balance for neutrality.
More from The Steward →This Week's Edition
21 October 2025
133 articles
Related Articles
Related Articles
More Stories
